Morgan Stanley analyst Shoji Sato downgraded Ibiden (IBIDF) to Equal Weight from Overweight with a price target of 13,000 yen, up from 9,500 yen. Though the firm expects continued earnings growth, additional upside is likely to be limited given that the stock has already increased 179% since February 28, the analyst tells investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBIDF:
- Ibiden Co: Positioned for Growth Amid AI and Semiconductor Industry Expansion
- Major Bank Says Asia Leads in AI Stocks – Which Are the Best to Buy?
- IBIDEN CO. Reports Strong Q2 Earnings Growth
- IBIDEN Announces Stock Split and Dividend Forecast Update
- IBIDEN Introduces Progressive Dividends and Announces Interim Dividend